Comparative costs and potential affordability of a multifaceted intervention to improve treatment outcomes among people with HIV who inject drugs in Russia: economic evaluation of the LINC-II randomized controlled trial.

Authors:
Rosen S; Blokhina E; Truong V; Bereznicka A; Gnatienko N and 6 more

Journal:
J Int AIDS Soc

Publication Year: 2024

DOI:
10.1002/jia2.26208

PMCID:
PMC10895073

PMID:
38403887

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: J Int AIDS Soc

Detailed journal information not available.

Publication Details

Subject Category: Infectious Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"COMPETING INTERESTS The authors declare that there are no competing interests."

Evidence found in paper:

"FUNDING This study was supported by a grant from the National Institute on Drug Abuse (R01DA045547) and the Providence/Boston Center for AIDS Research (P30AI042853)."

Evidence found in paper:

"Clinical Trial Number NCT03290391"

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025